Literature DB >> 19788250

Development of different analysis platforms with LC-MS for pharmacokinetic studies of protein drugs.

Qiaozhen Lu1, Xiaoyang Zheng, Thomas McIntosh, Hugh Davis, Jennifer F Nemeth, Chuck Pendley, Shiaw-Lin Wu, William S Hancock.   

Abstract

Three different analysis platforms using LC-MS were successfully developed for pharmacokinetic (PK) studies of an antibody drug in serum. These analysis platforms can be selectively used for different types of protein drugs, which ranged from a very specific for a particular drug (antibody enrichment) to a less specific for any antibody drugs with an Fc domain (protein A enrichment), and to a very generic method that can be used for any protein drugs (albumin depletion method). In this manner, the three platforms will be applicable to a wide range of antibody therapeutic studies for different species. The analysis using an albumin depletion method (with sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)) achieved the detection of the drug (to 1 ng) in an aliquot of serum (30 microL) with a 5-order magnitude of linearity. The analysis using protein A enrichment (with SDS-PAGE) achieved the detection of the drug at a 50-fold lower level (to 0.02 ng). Without the use of SDS-PAGE for separation, the use of protein A enrichment achieved the detection to 10 ng and using the antidrug antibody enrichment achieved the detection to 0.1 ng, with a similar linear dynamic range. These three analysis platforms produced good agreement with a mimic PK study of the drug in monkey serum, as compared to the enzyme-linked immunosorbent assay (ELISA) approach. In addition, these analysis platforms can be selectively applied for PK studies of drugs with different requirements of development time and resources. Such as, the antibody enrichment method can be used in a high-throughput manner but limited to a specific protein drug only. On the other hand, the albumin depletion method can be applied to many types of protein drugs but with the laborious sample preparation steps (SDS-PAGE and the subsequent in-gel digestion). When antidrug antibodies are not available for antibody drugs or the sensitivity requirement is not stringent (e.g., >10 ng), using protein A enrichment (without using SDS-PAGE) seems to be a good choice for PK studies which require fast throughput.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19788250      PMCID: PMC2788961          DOI: 10.1021/ac901991x

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  25 in total

1.  Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins.

Authors:  Leigh Anderson; Christie L Hunter
Journal:  Mol Cell Proteomics       Date:  2005-12-06       Impact factor: 5.911

2.  Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry.

Authors:  Tao Liu; Wei-Jun Qian; Heather M Mottaz; Marina A Gritsenko; Angela D Norbeck; Ronald J Moore; Samuel O Purvine; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-07-19       Impact factor: 5.911

3.  LC-MS/MS approach for quantification of therapeutic proteins in plasma using a protein internal standard and 2D-solid-phase extraction cleanup.

Authors:  Ziping Yang; Michael Hayes; Xinping Fang; Michael P Daley; Seth Ettenberg; Francis L S Tse
Journal:  Anal Chem       Date:  2007-11-14       Impact factor: 6.986

4.  Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution.

Authors:  Hasmik Keshishian; Terri Addona; Michael Burgess; Eric Kuhn; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2007-10-15       Impact factor: 5.911

5.  Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry.

Authors:  Olivier Heudi; Samuel Barteau; Dieter Zimmer; Joerg Schmidt; Kurt Bill; Natalie Lehmann; Christian Bauer; Olivier Kretz
Journal:  Anal Chem       Date:  2008-05-09       Impact factor: 6.986

6.  Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies.

Authors:  M Svenson; P Geborek; T Saxne; K Bendtzen
Journal:  Rheumatology (Oxford)       Date:  2007-12       Impact factor: 7.580

7.  Proteomic analysis of high-grade dysplastic cervical cells obtained from ThinPrep slides using laser capture microdissection and mass spectrometry.

Authors:  Ye Gu; Shiaw-Lin Wu; Jane L Meyer; William S Hancock; Lawrence J Burg; James Linder; David W Hanlon; Barry L Karger
Journal:  J Proteome Res       Date:  2007-09-29       Impact factor: 4.466

8.  Strategic use of immunoprecipitation and LC/MS/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosis.

Authors:  Michael J Berna; Yuejun Zhen; David E Watson; John E Hale; Bradley L Ackermann
Journal:  Anal Chem       Date:  2007-04-21       Impact factor: 6.986

Review 9.  Immunogenicity of therapeutic proteins: clinical implications and future prospects.

Authors:  Huub Schellekens
Journal:  Clin Ther       Date:  2002-11       Impact factor: 3.393

10.  Selected reaction monitoring for quantitative proteomics: a tutorial.

Authors:  Vinzenz Lange; Paola Picotti; Bruno Domon; Ruedi Aebersold
Journal:  Mol Syst Biol       Date:  2008-10-14       Impact factor: 11.429

View more
  6 in total

1.  Ligand-binding mass spectrometry to study biotransformation of fusion protein drugs and guide immunoassay development: strategic approach and application to peptibodies targeting the thrombopoietin receptor.

Authors:  Michael P Hall; Colin Gegg; Kenneth Walker; Christopher Spahr; Robert Ortiz; Vimal Patel; Steven Yu; Liana Zhang; Hsieng Lu; Binodh DeSilva; Jean W Lee
Journal:  AAPS J       Date:  2010-07-13       Impact factor: 4.009

2.  Characterization and comparison of disulfide linkages and scrambling patterns in therapeutic monoclonal antibodies: using LC-MS with electron transfer dissociation.

Authors:  Yi Wang; Qiaozhen Lu; Shiaw-Lin Wu; Barry L Karger; William S Hancock
Journal:  Anal Chem       Date:  2011-03-23       Impact factor: 6.986

Review 3.  Dying to protect: cell death and the control of T-cell homeostasis.

Authors:  Kun-Po Li; Sharmila Shanmuganad; Kaitlin Carroll; Jonathan D Katz; Michael B Jordan; David A Hildeman
Journal:  Immunol Rev       Date:  2017-05       Impact factor: 12.988

Review 4.  Toward sensitive and accurate analysis of antibody biotherapeutics by liquid chromatography coupled with mass spectrometry.

Authors:  Bo An; Ming Zhang; Jun Qu
Journal:  Drug Metab Dispos       Date:  2014-09-02       Impact factor: 3.922

5.  Genome and Transcriptome Sequences Reveal the Specific Parasitism of the Nematophagous Purpureocillium lilacinum 36-1.

Authors:  Jialian Xie; Shaojun Li; Chenmi Mo; Xueqiong Xiao; Deliang Peng; Gaofeng Wang; Yannong Xiao
Journal:  Front Microbiol       Date:  2016-07-19       Impact factor: 5.640

6.  Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect Correction.

Authors:  Aline Talhouk; Stefan Kommoss; Robertson Mackenzie; Martin Cheung; Samuel Leung; Derek S Chiu; Steve E Kalloger; David G Huntsman; Stephanie Chen; Maria Intermaggio; Jacek Gronwald; Fong C Chan; Susan J Ramus; Christian Steidl; David W Scott; Michael S Anglesio
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.